• 課程目錄
  • 專家簡介
  • 課程簡介
  • 評論

Obseva: The power of the GnRH antagonist MoA to personalize fibroid management

  • Introduction – The E2 theory and Linzagolix: a new oral GnRH antagonist, Felice Petraglia (Italy)

  • Heavy menstrual bleeding due to uterine fibroids: Lingazolix efficacy and safety, Hugh Taylor (USA)

  • Hormonal add-back therapy in the treatment of uterine fibroids, Jacques Donnez (Belgium)

評論文章